Trials / Completed
CompletedNCT04906564
RNF213 Variants and Collateral Vessels in Moyamoya Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Beijing Tiantan Hospital · Academic / Other
- Sex
- All
- Age
- 4 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to detect the association between RNF213 variants and collateral vessels in patients with moyamoya disease.
Detailed description
Moyamoya disease (MMD) is a chronic cerebrovascular disorder characterized by the presence of occlusion which occurs at the internal carotid arteries and their main branches during the development of a basal collateral network. The ring finger 213 (RNF213) was identified as a strong susceptibility gene in patients with MMD in East Asia. The role of RNF213 variants in pathogenesis of MMD is still unclear. Specific "moyamoya vessels" correlate with the onset of stroke. The purpose of this study is to investigate the relationship between RNF213 variants and collateral vessels in patients with moyamoya disease, and provide potential pathogenesis of moyamoya disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Identification of genetic variants | Identification of genetic variants |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
- First posted
- 2021-05-28
- Last updated
- 2022-02-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04906564. Inclusion in this directory is not an endorsement.